Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-acting octreotide for portal hypertension
ChiCTR-TRC-13003424Phase 4Completed
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Mar 2012
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4 trial of octreotide in Portal Hypertension (PH) (3 arms), sponsored by Shanghai Sixth People's Hospital. Primary endpoints: Hepatic venous pressure gradient and Vascular endothelial growth factor. Started Mar 2012; status: completed.
02
Drugs
octreotide
03
Conditions
Portal Hypertension (PH)
Beyond the preview
Go deeper on ChiCTR-TRC-13003424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003424.